Teva Pharmaceuticals President & CEO Richard Francis, discusses why Teva chose to make the change now and what will be different for investors as the shares move from ADRs to direct NYSE trading. He speaks with Romaine Bostick & Isabelle Lee on "The Close." (Source: Bloomberg)
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.